Silibinin inhibits prostate cancer cells- and RANKL-induced...

Molecular Carcinogenesis 2014 / 03 Vol. 53; Iss. 3

Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells

Kavitha, Chandagirikoppal V., Deep, Gagan, Gangar, Subhash C., Jain, Anil K., Agarwal, Chapla, Agarwal, Rajesh
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
53
Language:
english
Journal:
Molecular Carcinogenesis
DOI:
10.1002/mc.21959
Date:
March, 2014
File:
PDF, 977 KB
english, 2014
Conversion to is in progress
Conversion to is failed